Juvena Therapeutics
4 known investors
Juvena Therapeutics develops biologics derived from human secreted proteins to treat aging-related diseases, using AI-enabled drug discovery to identify tissue-restorative therapeutics for muscle and metabolic disorders.
Founders & leadership
JO
Jeremy O'Connell, PhDChief Scientific Officer and Co-Founder
HY
Hanadie Yousef, PhDExecutive Advisor and Co-Founder
Investors · 4
In the news
- Regenerative Medicine Startup Funding (2026) – New Market Pitchnewmarketpitch.com · 2026
- Juvena lands $33.5m to advance more regenerative biologics to the cliniclongevity.technology · 2026
- Juvena Therapeutics Raises $33.5M in Series B Fundingfinsmes.com · 2026
- Juvena Therapeutics Raises $33.5M Series B Led by Bison Ventures to Advance Regenerative Biologics Pipelinebusinesswire.com · 2026
- Juvena Therapeutics has filed a notice of an exempt offering of securities to raise $41 Million in New Funding. - intelligence360intelligence360.news · 2025
- Juvena Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2023